T. Rowe Price Associates’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.5M Sell
346,683
-223,287
-39% -$29.1M ﹤0.01% 887
2025
Q4
$69.3M Buy
569,970
+171,810
+43% +$21.6M 0.01% 714
2025
Q3
$44.7M Buy
398,160
+260,270
+189% +$30.5M ﹤0.01% 834
2025
Q2
$18.5M Buy
137,890
+2,192
+2% +$241K ﹤0.01% 977
2025
Q1
$9.13M Sell
135,698
-122,947
-48% -$8.46M ﹤0.01% 1131
2024
Q4
$16.1M Sell
258,645
-34,821
-12% -$3.24M ﹤0.01% 1039
2024
Q3
$46.1M Sell
293,466
-36,968
-11% -$5.7M 0.01% 778
2024
Q2
$49.8M Buy
330,434
+33,110
+11% +$3.97M 0.01% 727
2024
Q1
$22M Buy
297,324
+22,223
+8% +$1.83M ﹤0.01% 955
2023
Q4
$21.7M Buy
275,101
+153,861
+127% +$9.28M ﹤0.01% 935
2023
Q3
$6.64M Buy
121,240
+105,319
+662% +$7.58M ﹤0.01% 1131
2023
Q2
$1.34M Buy
15,921
+880
+6% +$67.4K ﹤0.01% 1652
2023
Q1
$1.14M Buy
15,041
+529
+4% +$36.6K ﹤0.01% 1724
2022
Q4
$896K Buy
14,512
+288
+2% +$15.3K ﹤0.01% 1830
2022
Q3
$594K Buy
14,224
+5,803
+69% +$252K ﹤0.01% 2042
2022
Q2
$265K Buy
8,421
+171
+2% +$4.56K ﹤0.01% 2495
2022
Q1
$222K Sell
8,250
-178,013
-96% -$3.19M ﹤0.01% 2676
2021
Q4
$3.57M Buy
+186,263
New +$4.67M ﹤0.01% 1550
2021
Q1
Sell
-336,789
Closed -$6.7M 2873
2020
Q4
$6.7M Sell
336,789
-89,442
-21% -$1.32M ﹤0.01% 1403
2020
Q3
$5.87M Buy
426,231
+185
+0% +$3.17K ﹤0.01% 1385
2020
Q2
$7.63M Sell
426,046
-33,080
-7% -$517K ﹤0.01% 1337
2020
Q1
$5.55M Sell
459,126
-62,495
-12% -$1.05M ﹤0.01% 1329
2019
Q4
$9.92M Buy
+521,621
New +$9.58M ﹤0.01% 1313

Other funds holding TMDX